Dr. Melissa Youssef Beshay, MD

Dr. Beshay practices at Emory Saint Joseph's Hospital in Atlanta, Georgia, part of Emory University.

Dr. Beshay's NPI, 1174028682, was assigned on March 27, 2018. Dr. Beshay graduated from Medical University of South Carolina College of Medicine in 2018. Dr. Beshay holds Georgia license 88228.

Dr. Beshay's primary practice is Emory Saint Joseph's Hospital, at 5665 Peachtree Dunwoody Road, Atlanta, GA 30342 in Fulton County. The practice phone is (678) 843-7001.

Dr. Beshay's primary practice is Emory Saint Joseph's Hospital in Atlanta, Georgia, part of Emory University. Dr. Beshay is also affiliated with Emory University Hospital. The medical group on file is Emory Clinic. Dmand AI also links Dr. Beshay to 1 more hospital, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Beshay practices, 3 sites in all. Vendor and product names are available with a free account.

Hospitalist is Dr. Beshay's primary specialty in the NPI Registry, under taxonomy code 208M00000X. Dmand AI has Dr. Beshay's licenses on file in 2 states: Georgia and New York.

CMS data shows 644 Medicare services from Dr. Beshay across 3 procedure codes in 2024, for 309 Medicare patients. Medicare paid $57,014 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 309 Medicare patients who saw Dr. Beshay in 2024. The largest group is 75 to 84, with 121 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 17% are also on Medicaid. Their average risk score is 2.40, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Beshay's median patient age at 79, with 53% women.

In 2024, Dr. Beshay wrote 444 Medicare Part D claims for 130 patients. 91% of them were for generic drugs. CMS names the drug for 191 of them, across 11 drugs with 11 or more claims each, at $10,236 in total drug cost. In 2023, CMS named 39 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 95 out of 100 for Dr. Beshay for performance year 2024, reported through an alternative payment model (APM). Dr. Beshay accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 1 general payment to Dr. Beshay from 1 drug or device company in 2020. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $56.

Dr. Beshay graduated from Medical University of South Carolina College of Medicine in 2018.